Literature DB >> 19058673

[Takotsubo cardiomyopathy: a consensus document].

Salvatore Novo1, Yoshihiro Akashi, Eloisa Arbustini, Pasquale Assennato, Salvatore Azzarelli, Giuseppe Barbaro, Giovanni Fazio, Francesco Fedele, Massimo Giordan, Pietro Mazzarotto, Maria Grazia Modena, Giuseppina Novo, Guido Parodi, Mario Previtali, Claudio Rapezzi, Francesca Sconci, Paolo Sganzerla, Francesco Tona, Jorge A Salerno-Uriarte.   

Abstract

Takotsubo cardiomyopathy is a syndrome characterized by acute regional systolic dysfunction of the left ventricle, frequently related to psycho-physical acute stress, and usually reversible. This rare syndrome involves more often the female sex with the highest frequency of occurrence between the seventh and eighth decade of life. Etiology has not been clarified yet and several hypotheses have been postulated: multiple epicardial coronary artery damage, abnormal coronary microcirculation, catecholamine-mediated cardiac toxicity, and neurogenic stunning. Clinical presentation is not easy to distinguish from an acute coronary syndrome: chest pain at rest or dyspnea, new-onset electrocardiographic changes, characterized by ST-segment elevation or T-wave inversion. Coronary angiography, which should be performed within 48 h of symptom onset in order to be diagnostic, excludes the presence of significant atherosclerotic stenosis or plaque rupture. Ventricular angiography shows the typical regional wall motion abnormalities (apical akinesia and hyperkinesia of the mid-basal segments) that give to the syndrome its name (takotsubo is a traditional Japanese octopus trap or pot). Echocardiography performed in the acute phase also evidences wall motion abnormalities that characteristically regress in the following days. There is no specific treatment for this syndrome, but supportive and symptomatic therapy is usually administered.

Entities:  

Mesh:

Year:  2008        PMID: 19058673

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  8 in total

1.  When sepsis affects the heart: A case report and literature review.

Authors:  Giuseppe Clemente; Antonino Tuttolomondo; Daniela Colomba; Rosaria Pecoraro; Chiara Renda; Vittoriano Della Corte; Carlo Maida; Irene Simonetta; Antonio Pinto
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

2.  Takotsubo cardiomyopathy with secondary coronary embolus.

Authors:  Thomas David Heseltine; Vellore J Karthikeyan; John Morris
Journal:  BMJ Case Rep       Date:  2014-04-25

Review 3.  Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning?

Authors:  Ilan S Wittstein
Journal:  Cell Mol Neurobiol       Date:  2012-07       Impact factor: 5.046

4.  Heart rate variability and nonlinear dynamic analysis in patients with stress-induced cardiomyopathy.

Authors:  Goran Krstacic; Gianfranco Parati; Dragan Gamberger; Paolo Castiglioni; Antonija Krstacic; Robert Steiner
Journal:  Med Biol Eng Comput       Date:  2012-08-19       Impact factor: 2.602

5.  Characteristics of coronary microcirculatory function in patients with Takotsubo syndrome.

Authors:  Giuseppina Novo; Angelo Quagliana; Dario Buccheri; Salvatore Rizzo; Salvatore Giambanco; Francesco Giambanco; Salvatore Evola; Giovanna Geraci; Salvatore Novo
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Gender Differences in Post-Traumatic Stress.

Authors:  Maria Grazia Modena; Daniele Pettorelli; Giulia Lauria; Elisa Giubertoni; Erminio Mauro; Valentina Martinotti
Journal:  Biores Open Access       Date:  2017-02-01

7.  Over the Exceptions: Psychiatric Disorder, Medical Stress, and Takotsubo Cardiomyopathy.

Authors:  Francesca De Angelis; Ketty Savino; Viviana Oliva; Alessandra Biadetti; Stefano Coiro; Giuseppe Ambrosio
Journal:  J Cardiovasc Echogr       Date:  2017 Apr-Jun

8.  Chronic Stress and Early Recurrence of Takotsubo Cardiomyopathy: A Clinical Case.

Authors:  Giuseppina Novo; Patrizia Carità; Laura Ajello; Pasquale Assennato
Journal:  J Cardiovasc Echogr       Date:  2014 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.